To date, it has been found that ACK1 interacts with a variety of receptor tyrosine kinases (EGFR), oncoproteins (AKT), tumor suppressor proteins (Wwox), and epigenetic modification regulatory proteins (KDM3A) in breast cancer [5, 6, 11, 33, 40]. This evidence concerns the gene TCHP and breast carcinoma.